INS and type 2 diabetes mellitus: Indeed, a recent meta-analysis has shown that although insulin therapy remains the preferred approach for glycemic management in hospitalized patients, treatment with DPP-4 inhibitors may be appropriate in select patients with type 2 diabetes, including those with well-managed diabetes and those with established noninsulin-requiring diabetes nearing hospital discharge [42].